Vir Biotechnology, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Vir Biotechnology, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Vir Biotechnology, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $357M, a 74.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $357M +$152M +74.4% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $205M +$159M +348% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $45.7M -$114M -71.4% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $160M +$74.1M +86.3% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $85.8M +$42.3M +97.4% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $43.5M Dec 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.